Lipfendra

Merck headquarters in Rahway
Jul 17, 2026

Merck wins FDA approval for oral LDL cholesterol drug

Merck won FDA approval for Lipfendra, the first oral PCSK9 inhibitor for adults with high LDL cholesterol and hypercholesterolemia.